Makale detayı · 2021 · article
Adherence to best practice consensus guidelines for familial Mediterranean fever: a modified Delphi study among paediatric rheumatologists in Turkey
ISSN0172-8172
YÖKSİS
OpenAlex
Açık erişim · bronze
Yıl2021
Atıf12OpenAlex
Atıf10Semantic Scholar · 1 etkili
Yüzdelik%61,5
FWCI0,591,00 = dünya ortalaması
Scopus (SJR)Q2
WoS (JCR)Q3
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıRheumatology International
- Katalog eşleşmesi (ISSN)Rheumatology International
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
- Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)
Özet
Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
12atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 19 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2022 Colchicine resistance: Associated factors and its effect on health‐related quality of life in patients with familial Mediterranean feverAtıf 15 · OpenAlex
- 2022 Colchicine resistance: Associated factors and their effect on health-related quality of life in patients with familial Mediterranean feverAtıf 15 · OpenAlex
- 2022 Colchicine Resistance: Associated Factors and Its Effect on Health-Related Quality of Life in Patients with Familial Mediterranean FeverAtıf 15 · OpenAlex
- 2023 Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean feverAtıf 12 · OpenAlex
- 2023 Subclinical enthesitis in enthesitis-related arthritis and sacroiliitis associated with familial Mediterranean feverAtıf 12 · OpenAlex
- 2023 Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean feverAtıf 12 · OpenAlex
- 2022 Real-life data on tapering or discontinuation of canakinumab therapy in patients with familial Mediterranean feverAtıf 8 · OpenAlex
- 2021 The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patientsAtıf 8 · OpenAlex
- 2021 The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patientsAtıf 8 · OpenAlex
- 2024 Factors Associated With Successful Withdrawal of Biologic Agents in Children With Colchicine-Resistant Familial Mediterranean FeverAtıf 3 · OpenAlex